Alison Innes

1.6k total citations
9 papers, 647 citations indexed

About

Alison Innes is a scholar working on Genetics, Epidemiology and Hematology. According to data from OpenAlex, Alison Innes has authored 9 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 3 papers in Epidemiology and 3 papers in Hematology. Recurrent topics in Alison Innes's work include Inflammatory Bowel Disease (4 papers), Microscopic Colitis (3 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Alison Innes is often cited by papers focused on Inflammatory Bowel Disease (4 papers), Microscopic Colitis (3 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Alison Innes collaborates with scholars based in United States, United Kingdom and South Africa. Alison Innes's co-authors include Stefan Schreiber, Paul Rutgeerts, Michael A. Kamm, Michael Staun, Çharles N. Bernstein, Richard N. Fedorak, Michel Boivin, Ole Østergaard Thomsen, Trevor A. Winter and Subrata Ghosh and has published in prestigious journals such as Gastroenterology, The American Journal of Gastroenterology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Alison Innes

9 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Innes United States 6 492 408 167 113 98 9 647
Jonathan Crawshaw United Kingdom 5 455 0.9× 260 0.6× 341 2.0× 195 1.7× 65 0.7× 7 762
Matthias Jürgens Germany 11 630 1.3× 443 1.1× 391 2.3× 162 1.4× 53 0.5× 19 884
S Targan United States 12 425 0.9× 255 0.6× 374 2.2× 141 1.2× 57 0.6× 20 740
Sophie Tops Belgium 14 531 1.1× 406 1.0× 308 1.8× 131 1.2× 20 0.2× 16 643
Anne‐Emmanuelle Berger France 12 355 0.7× 280 0.7× 212 1.3× 78 0.7× 24 0.2× 41 547
Jasdeep Mann United States 4 422 0.9× 115 0.3× 224 1.3× 205 1.8× 20 0.2× 6 506
Jane Burgess Australia 14 210 0.4× 344 0.8× 162 1.0× 98 0.9× 102 1.0× 21 670
Abolhasan Farhoudi Iran 12 202 0.4× 103 0.3× 406 2.4× 49 0.4× 98 1.0× 14 542
Evanthia Zampeli Greece 9 181 0.4× 140 0.3× 127 0.8× 122 1.1× 15 0.2× 26 379
Jason Daniels United States 12 105 0.2× 169 0.4× 218 1.3× 224 2.0× 13 0.1× 27 647

Countries citing papers authored by Alison Innes

Since Specialization
Citations

This map shows the geographic impact of Alison Innes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Innes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Innes more than expected).

Fields of papers citing papers by Alison Innes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Innes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Innes. The network helps show where Alison Innes may publish in the future.

Co-authorship network of co-authors of Alison Innes

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Innes. A scholar is included among the top collaborators of Alison Innes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Innes. Alison Innes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Shapiro, Amy D., Johnny Mahlangu, David J. Perry, et al.. (2017). Treatment of bleeding episodes with recombinant factor VIII Fc fusion protein in A‐LONG study subjects with severe haemophilia A. Haemophilia. 23(3). 392–399. 10 indexed citations
2.
Windyga, Jerzy, M. V. Ragni, John Pasi, et al.. (2015). Subject-Reported Changes in Physical Activity During The B-LONG Study of Recombinant Factor IX FC Fusion Protein (RFIXFC) For Severe Haemophilia B. Queen Mary Research Online (Queen Mary University of London). 1 indexed citations
3.
Ионин, Б. И., Robert J. Hopkins, Thomas L. Rudge, et al.. (2013). Evaluation of Immunogenicity and Efficacy of Anthrax Vaccine Adsorbed for Postexposure Prophylaxis. Clinical and Vaccine Immunology. 20(7). 1016–1026. 53 indexed citations
4.
Feagan, Brian G., William J. Sandborn, Gary R. Lichtenstein, et al.. (2006). CDP571, a humanized monoclonal antibody to tumour necrosis factor‐α, for steroid‐dependent Crohn's disease: a randomized, double‐blind, placebo‐controlled trial. Alimentary Pharmacology & Therapeutics. 23(5). 617–628. 31 indexed citations
5.
Schreiber, Stefan, Paul Rutgeerts, Richard N. Fedorak, et al.. (2005). A Randomized, Placebo-Controlled Trial of Certolizumab Pegol (CDP870) for Treatment of Crohn’s Disease. Gastroenterology. 129(3). 807–818. 442 indexed citations
6.
Winter, Trevor A., et al.. (2004). Intravenous CDP870, a PEGylated Fab′ fragment of a humanized antitumour necrosis factor antibody, in patients with moderate‐to‐severe Crohn's disease: an exploratory study. Alimentary Pharmacology & Therapeutics. 20(11-12). 1337–1346. 92 indexed citations
7.
Mamula, Petar, Stanley A. Cohen, George D. Ferry, et al.. (2004). CDP571, a Humanized Anti-Tumor Necrosis Factor-α Monoclonal Antibody in Pediatric Crohn’s Disease. Inflammatory Bowel Diseases. 10(6). 723–730. 13 indexed citations
8.
Schreiber, Stefan, Paul Rutgeerts, Alison Innes, & Jatin Patel. (2003). CDP870, A PEGYLATED HUMANIZED ANTI-TNF ANTIBODY FRAGMENT, OFFERS PARTICULAR BENEFIT TO CROHNʼS DISEASE PATIENTS WITH ELEVATED C-REACTIVE PROTEIN. The American Journal of Gastroenterology. 98. S245–S245. 2 indexed citations
9.
Innes, Alison, et al.. (1983). Quadriplegia following venous air embolism during posterior fossa exploration. A case report.. PubMed. 63(10). 378–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonathan Crawshaw Breakdown of academic impact, for papers by Matthias Jürgens Breakdown of academic impact, for papers by S Targan Breakdown of academic impact, for papers by Sophie Tops Breakdown of academic impact, for papers by Anne‐Emmanuelle Berger Breakdown of academic impact, for papers by Jasdeep Mann Breakdown of academic impact, for papers by Jane Burgess Breakdown of academic impact, for papers by Abolhasan Farhoudi Breakdown of academic impact, for papers by Evanthia Zampeli Breakdown of academic impact, for papers by Jason Daniels
Rankless by CCL
2026